Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Relay Therapeutics (RLAY) Receivables - Net (2020 - 2023)

Relay Therapeutics (RLAY) has disclosed Receivables - Net for 4 consecutive years, with $211000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Receivables - Net fell 12.45% to $211000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $211000.0, a 12.45% decrease, with the full-year FY2022 number at $306000.0, down 24.07% from a year prior.
  • Receivables - Net was $211000.0 for Q3 2023 at Relay Therapeutics, up from $78000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $75.0 million in Q4 2020 to a low of $78000.0 in Q2 2023.
  • A 4-year average of $7.1 million and a median of $286000.0 in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: plummeted 99.46% in 2021, then rose 6.32% in 2023.
  • Relay Therapeutics' Receivables - Net stood at $75.0 million in 2020, then tumbled by 99.46% to $403000.0 in 2021, then dropped by 24.07% to $306000.0 in 2022, then crashed by 31.05% to $211000.0 in 2023.
  • Per Business Quant, the three most recent readings for RLAY's Receivables - Net are $211000.0 (Q3 2023), $78000.0 (Q2 2023), and $286000.0 (Q1 2023).